Cookie Consent by FreePrivacyPolicy.com

Skinive

Skinive is a simple way to identify and assess the risks of skin diseases using your smartphone! Simply take a picture of your skin pathology and send it to the Skinive app for analysis by AI algorithms based on the largest dermatological database in the world.
Send Message

Premium Details Available

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
blurred values
Growth rate month over month
blurred values
Monthly revenue context
blurred values
Number of paying customers
blurred values
Monthly active users
blurred values

INVESTMENTS

Do you have a lead investor?
blurred values
How much have you raised in the past?
blurred values
How much of this round already committed?
blurred values
When are you aiming to close this round?
blurred values

TEAM

How much time do the founders spend on the business?
blurred values
Is there a founder with previous co-founder / c-level at startup experience?
blurred values
Is there a founder with previous Sector Experience?
blurred values
Is there a founder with previous Exit Experience?
blurred values
What percentage of company is owned by founders?
blurred values
Is there a women founder with at least 5% of the shares?
blurred values
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
blurred values
Graduation year from EUR, Erasmus MC or TUDelft
blurred values

OTHER

Year founded
blurred values
Patent status
blurred values
Start your free trial today to explore this information.
Start Free Trial

Premium Details

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
€5K - €10K
Growth rate month over month
8-12%
Monthly revenue context
We are now using a subscription model for personalised app usage, and a SaaS model for Skinive Cloud. In 2023, we also plan to introduce a number of new services, such as teledermatology and personalised medication selection, which will enable us to significantly increase the average check.
Number of paying customers
200
Monthly active users
25000

INVESTMENTS

Do you have a lead investor?
Almost
How much have you raised in the past?
550000
How much of this round already committed?
500000
When are you aiming to close this round?
Q2

TEAM

How much time do the founders spend on the business?
100%
Is there a founder with previous co-founder / c-level at startup experience?
Yes
Is there a founder with previous Sector Experience?
Yes
Is there a founder with previous Exit Experience?
No
What percentage of company is owned by founders?
70-79% owned by founders
Is there a women founder with at least 5% of the shares?
No
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
None of these
Graduation year from EUR, Erasmus MC or TUDelft

OTHER

Year founded
2020
Patent status
No

Basic details

Amount raising
€1,500,000
Country
Netherlands
Industry
AI/ML, Health, MedTech
Founders
linkedin profile of founderlinkedin profile of founderlinkedin profile of founder
Last updated:
March 12, 2023

Key Achievements

  • ✅ 150K Skinive App Installs (Aug’22- Feb’23) ✅ B2B - 8 paying clients ✅ B2C: Reaching break-even point in some countries
  • 🌟 Company shows good Product-Market-Fit: +900,000 skin conditions have been analysed, with around 10% of cases identified as health risks, first revenue of €55K in Q3-Q4 2022. 🌟 Technology leaders: first among competitors developed a solution for 1-5 skin phototypes that covers over 50 skin conditions with +95% accuracy (skin cancer, HPV, herpes, mycosis, eczema, psoriasis, dermatitis, acne, etc ) 🌟 Skinive has proven the ability to grow fast: The company reached 100K users in 5 months and has a clear strategy to capture meaningful global market share

Contact this startup to discuss investments

Try it! It's free, no account needed.
This startup has indicated interest to meet with potential investors. If you are interested, please fill out the contact form below and your message will be forwarded to the startup.
Oops! Something went wrong while sending your message.

Provide anonymous feedback

Startups greatly benefit from honest feedback from investors, but rarely receive it for numerous reasons. You can anonymously provide feedback here.
Your name and email address is not shared with the startup, but needed to avoid misusage.
Oops! Something went wrong while sending your message.